| |
|
|
|
|
|
|
|
|
|
|
| |
Pourkarim MR, Amini-Bavil-Olyaee S, Verbeeck J, Lemey P, Zeller M, Rahman M, Maes P, Nevens F, Van Ranst M.
Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B isolated from Belgian patients with different clinical manifestations.
J Med Virol . 2009;82(3):379-89 |
|
|
|
| |
De Keyser F, De La Brassine M, Lambert J, Lauwerys B, Louis E, Van Assche G, Van Gompel A, Westhovens R, Van Ranst M.
Preventie en behandeling van A/H1N1-influenza bij patiënten met immuungemedieerde inflammatoire aandoeningen onder immunotherapie.
Tijdschr Gen. 2009;66(2):57-64 |
|
|
|
|  |
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
Van Doorslaer K, Sidi AOMO, Zanier K, Rybin V, Deryckere F, Rector A, Burk RD, Lienau EK, Van Ranst M, Trave G.
Identification of unusual E6 and E7 proteins within avian papillomaviruses: cellular localization, biophysical characterization, and phylogenetic analysis.
J Virol . 2009;83(17):8759-70 |
|
|
| |
|
Pourkarim MR, Verbeeck J, Rahman M, Amini-Bavil-Olyaee S, Forier A-M, Lemey P, Maes P, Van Ranst M.
Phylogenetic analysis of hepatitis B virus full-length genomes reveals evidence for a large nosocomial outbreak in Belgium
.
J Clin Virol. 2009;46(1):61-8 |
|
|
| |
|
Maes P, Klempa B, Clement J, Matthijnssens J, Gajdusek DC, Krüger DH, Van Ranst M.
A proposal for new criteria for the classification of hantaviruses, based on S and M segment protein sequences
.
Infect Genet Evol . 2009;9(5):813-20 |
|
|
| |
|
Bányai K, Matthijnssens J, Szuecs G, Forgach P, Erdelyi K, Van Ranst M, Lorusso E, Decaro N, Elia G, Martella V.
Frequent rearrangement may explain the structural heterogeneity in the 11th genome segment of lapine rotaviruses - short communication
.
Acta Vet Hung. 2009;57(3):453-61 |
|
|
| |
|
Lin L, Libbrecht L, Verbeeck J, Verslype C, Roskams T, van Pelt J, Van Ranst M, Fevery J.
Quantitation of replication of the HCV genome in human livers with end-stage cirrhosis by strand-specific Real-Time RT-PCR Assay: methods and clinical relevance
.
J Med Virol . 2009;81(9):1569-75 |
|
|
| |
|
Bányai K, Martella V, Molnár P, Mihály I, Van Ranst M, Matthijnssens J.
Genetic heterogeneity in human G6P[14] rotavirus strains detected in Hungary suggests independent zoonotic origin
.
J Infection. 2009;59(3):213-5 |
|
|
| |
|
Maes P, Keyaerts E, Nlandu-Masunda V, Clement J, Van Ranst M.
Replication reduction neutralization test, a quantitative RT-PCR-based technique for the detection of neutralizing hantavirus antibodies.
J Virol Methods. 2009;159(2):295-9 |
|
|
| |
|
Keyaerts E, Li S, Vijgen L, Rysman E, Verbeeck J, Van Ranst M, Maes P.
Antiviral activity of chloroquine agains human coronavirus OC43 infection in newborn mice
.
Antimicrob Agents Chemother. 2009;53(8):3416-21 |
|
|
| |
|
Lagrou K, Bodéus M, Van Ranst M, Goubau P.
Evaluation of the new Architect Cytomegalovirus Immunoglobulin M (IgM), IgG, and IgG Avidity assays.
J Clin Microbiol. 2009;47(6):1695-9 |
|
|
| |
|
Alvarez R, Elbashir S, Borland T, Toudjarska I, Hadwiger P, John M, Roehl I, Morskaya SS, Martinello R, Kahn J, Van Ranst M, Tripp R, Ralph A, DeVincenzo JP, Pandey R, Maier M, Nechev L, Manoharan M, Kotelianski V, Meyers R.
RNA Interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy..
Antimicrob Agents Chemother. 2009;53(9):3952-62 |
|
|
| |
|
Bilcke J, Van Damme P, Van Ranst M, Hens N, Aerts M, Beutels P.
Estimating the incidence of symptomatic rotavirus infections: a systematic review and meta-analysis.
PloS. 2009;4(6):e6060 |
|
|
| |
|
Johne R, Mueller H, Rector A, Van Ranst M, Stevens H.
Rolling-circle amplification of viral DNA genomes using phi29 polymerases.
Trends Microbiol. 2009;17(5):205-11 |
  |
|
| |
|
Robaeys G, Nevens F, Stärkel P, Colle I, Van Eyken P, Bruckers L, Van Ranst M, Buntinx F.
Previous intravenous substance use and outcome of liver transplantation in patients with chronic hepatitis C infection.
Transplant Proc. 2009 Mar;41(2):589-94 |
 |
|
| |
|
Goegebuer T, Van Meensel B, Beuselinck K, Cossey V, Van Ranst M, Hanssens M, Lagrou K.
Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples.
J Clin Microbiol. 2009 Mar;47(3):660-5 |
|
|
| |
|
Robesyn E, De Schrijver K, Wollants E, Top G, Verbeeck J, Van Ranst M.
An outbreak of hepatitis A associated with the consumption of raw beef.
J Clin Virol. 2009 Jan;44:207-210 |
|
|
| |
|
Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J.
Triage of women with equivocal or low-grade cytology results. A meta-analysis of the HPV test positivity rate.
J Cell Mol Med. 2009 Jan |
|
|
| |
|
Matthijnssens J, Potgieter CA, Ciarlet M, Parreño V, Martella V, Bányai K, Garaicoechea L, Palombo EA, Novo L, Zeller M, Arista S, Gerna G, Rahman M, Van Ranst M.
Are human P[14] rotavirus strains the result of interspecies transmissions from sheep or other ungulates belonging to the mammalian order of artiodactyla?
J Virol. 2009 Apr;83(7):2917-29 |
|
|
| |
|
Clement J, Vercauteren J, Verstraeten WW, Ducoffre G, Barrios JM, Vandamme AM, Maes P, Van Ranst M.
Relating increasing hantavirus incidences to the changing climate: the mast connection.
Int J Health Geogr. 2009 Jan;8:1 |
|
|
| |
|
Maes P, Clement J, Van Ranst M.
Recent approaches in hantavirus vaccine development.
Expert Rev Vaccines. 2009 Jan;8(1):67-76 |
|
|
| |
|
Rehtanz M, Bossart GD, Doescher B, Rector A, Van Ranst M, Fair PA, Jenson AB, Ghim SJ.
Bottlenose dolphin (Tursiops truncatus) papillomaviruses: vaccine antigen candidates and screening test development.
Vet Microbiol. 2009 Jan;133(1-2):43-53 |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Jacobs JA, Van Ranst M.
Biometric fingerprinting for visa application: device and procedure are risk factors for infection transmission.
J Travel Med. 2008 Sep-Oct;15(5):335-43 |
|
|
| |
|
Stevens H, Rector A, Van Der Kroght K, Van Ranst M.
Isolation and cloning of two variant papillomaviruses from domestic pigs: Sus scrofa papillomaviruses type 1 variants a and b.
J Gen Virol. 2008 Oct;89(Pt 10):2475-81 |
|
|
| |
|
Verbeeck J, Van Kerschaever E, Wollants E, Beuselinck K, Stappaerts L, Van Ranst M.
Detection of perinatal cytomegalovirus infection and sensorineural hearing loss in Belgian infants by measurement of automated auditory brainstem response.
J Clin Microbiol. 2008 Nov;46(11):3564-8 |
|
|
| |
|
Van Laethem K, Schrooten Y, Covens K, Dekeersmaeker N, De Munter P, Van Wijngaerden E, Van Ranst M, Vandamme AM.
A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.
J Virol Methods. 2008 Nov;153(2):176-81 |
|
|
| |
|
Rahman M, Yang XL, Sun H, Mahzebin K, Verstappen NW, Novo L, Matthijnssens J, Van Ranst M.
Emerging G9 rotavirus strains in the northwest of China.
Virus Res. 2008 Oct;137(1):157-62 |
|
|
| |
|
Matthijnssens J, Ciarlet M, Rahman M, Attoui H, Bányai K, Estes MK, Gentsch JR, Iturriza-Gómara M, Kirkwood CD, Martella V, Mertens PP, Nakagomi O, Patton JT, Ruggeri FM, Saif LJ, Santos N, Steyer A, Taniguchi K, Desselberger U, Van Ranst M.
Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments.
Arch Virol. 2008;153(8):1621-9 |
|
|
| |
|
Rector A, Stevens H, Lacave G, Lemey P, Mostmans S, Salbany A, Vos M, Van Doorslaer K, Ghim SJ, Rehtanz M, Bossart GD, Jenson AB, Van Ranst M.
Genomic characterization of novel dolphin papillomaviruses provides indications for recombination within the Papillomaviridae.
Virology, 2008 Aug;378(1):151-61 |
|
|
| |
|
Yang XL, Matthijnssens J, Sun H, Muhamaiti J, Zhang B, Nahar S, Van Ranst M, Rahman M.
Temporal changes of rotavirus strain distribution in a city in the northwest of China, 1996-2005.
Int J Infect Dis. 2008 Nov;12(6):e11-7 |
|
|
| |
|
Vermeersch P, Van Ranst M, Lagrou K.
Validation of a strategy for HCV antibody testing with two enzyme immunoassays in a routine clinical laboratory.
J Clin Viro. 2008 Aug;42(4):394-8 |
|
|
| |
|
Peeters S, Stakenborg T, Reekmans G, Laureyn W, Lagae L, Van Aerschot A, Van Ranst M.
Impact of spacers on the hybridization efficiency of mixed self-assembled DNA/alkanethiol films.
Biosens bioelectron. 2008 Sep;24(1):72-7 |
|
|
| |
|
Bennett MD, Woolford L, Stevens H, Van Ranst M, Oldfield T, Slaven M, O'Hara AJ, Warren KS, Nicholls PK.
Genomic characterization of a novel virus found in papillomatous lesions from a southern brown bandicoot (Isoodon obesulus) in Western Australia.
Virology. 2008 Jun;376(1):173-82 |
|
|
| |
|
Verbeeck J, Van Assche G, Ryding J, Wollants E, Rans K, Vermeire S, Pourkarim MR, Noman M, Dillner J, Van Ranst M, Rutgeerts P.
JC viral loads in patients with Crohn's disease treated with immunosuppression: can we screen for elevated risk of progressive multifocal leukoencephalopathy?
Gut. 2008 Oct;57(10):1393-7 |
|
|
| |
|
Verbeeck J, Stanley MJ, Shieh J, Celis L, Huyck E, Wollants E, Morimoto J, Farrior A, Sablon E, Jankowski-Hennig M, Schaper C, Johnson P, Van Ranst M, Van Brussel M.
Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.
J Clin Microbiol. 2008 Jun;46(6):1901-6 |
|
|
| |
|
Clement J, Maes P, Van Ranst M.
Acute kidney injury in emerging, non-tropical infections.
Acta Clin Belg. 2008 Mar;21(1):49-60 |
|
|
| |
|
Matthijnssens J, Rahman M, Van Ranst M.
Two out of the 11 genes of an unusual human G6P[6] rotavirus isolate are of bovine origin.
J Gen Virology. 2008Oct;89(Pt 10):2630-5 |
|
|
| |
|
Ross RS, Verbeeck J, Viazov S, Lemey P, Van Ranst M, Roggendorf M.
Evidence for a complex mosaic genome pattern in a full-length Hepatitis C virus sequence.
Evol Bioinform Online. 2008;4:249-54 |
|
|
| |
|
Vijgen L, Moës E, Keyaerts E, Li S, Van Ranst M.
A pancoronavirus RT-PCR assay for detection of all known coronaviruses.
Methods Mol Biol. 2008;454:3-12 |
|
|
| |
|
Van Den Bossche MJ, Devriendt D, Weyne L, Van Ranst M.
Primary peritonitis combined with streptococcal toxic shock syndrome
following an upper respiratory tract infection caused by Streptococcus pyogenes.
Ned Tijdschr Geneeskd. 2008;152(15):891-4. |
|
|
| |
|
Maes P, Clement J, Cauwe B, Bonnet V, Keyaerts E, Robert A, Van Ranst M.
Truncated recombinant puumala virus nucleocapsid proteins protect mice against challenge in vivo.
Viral Immunol. 2008;21(1):49-60. |
|
|
| |
|
Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Deforche K, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Van Den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Vandamme AM, Van Laethem K.
Prevalence and Epidemiology of HIV Type 1 Drug Resistance among Newly Diagnosed Therapy-Naive Patients in Belgium from 2003 to 2006.
AIDS Res Hum Retroviruses. 2008. |
|
|
| |
|
Bilcke J, Van Damme P, De Smet F, Hanquet G, Van Ranst M, Beutels P.
The health and economic burden of rotavirus disease in Belgium.
Eur J Pediatr. 2008. |
|
|
| |
|
Smets K, Keymeulen A, Wollants E, Lagrou K, Van Ranst M, Padalko E.
Detection of enteroviral RNA on Guthrie card dried blood of a neonate with fatal Coxsackie B3 myocarditis on day 17.
J Clin Virol. 2008. |
|
|
| |
|
Matthijnssens J, Ciarlet M, Heiman E, Arijs I, Delbeke T, McDonald SM, Palombo EA, Iturriza-Gómara M, Maes P, Patton JT, Rahman M, Van Ranst M.
Full genome-based classification of rotaviruses reveals a common origin between human Wa-Like and porcine rotavirus strains and human DS-1-like and bovine rotavirus strains.
J Virol. 2008; 82(7):3204-19. |
|
|
| |
|
Stevens H, Rector A, Bertelsen MF, Leifsson PS, Van Ranst M.
Novel papillomavirus isolated from the oral mucosa of a polar bear does not cluster with other papillomaviruses of carnivores.
Vet Microbiol. 2008; |
|
|
| |
|
Sprangers B, Smets S, Sagaert X, Wozniak A, Wollants E, Van Ranst M, Debiec-Rychter M, Sciot R, Vanrenterghem Y, Kuypers DR.
Posttransplant Epstein-Barr virus-associated myogenic tumors: case report and review of the literature.
Am J Transplant. 2008; 8(1):253-8. |
|
|
| |
|
Verbeeck J, Peigue-Lafeuille H, Ross RS, Abergel A, Nevens F, Van der Merwe S, Van Ranst M, Henquell C.
HCV genotype 5: Epidemiology and spread of an uncommon genotype.
Journal of Clinical Virology 41 (2008) 170–171. |
|
|
| |
|
Clement J, Maes P, Ducoffre G, Loock FV, van Ranst M.
Hantaviruses: underestimated respiratory viruses?
Clin Infect Dis. 2008; 46(3):477-9. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Clement J, Maes P, Van Ranst M.
Acute kidney injury in emerging, non-tropical infections.
Acta Clin Belg. 2007 Nov-Dec;62(6):387-95. |
|
|
| |
|
Robaeys G, De Bie J, Wichers MC, Bruckers L, Nevens F, Michielsen P, Van Ranst M, Buntinx F.
Early prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeks.
World J Gastroenterol. 2007; 13(43):5736-40. |
|
|
| |
|
Woolford L, Rector A, Van Ranst M, Ducki A, Bennett MD, Nicholls PK, Warren KS, Swan RA, Wilcox GE, O'Hara AJ.
A novel virus detected in papillomas and carcinomas of the endangered western barred bandicoot (Perameles bougainville) exhibits genomic features of both the Papillomaviridae and Polyomaviridae.
J Virol. 2007; 81(24):13280-90. |
|
|
| |
|
Zlateva KT, Vijgen L, Dekeersmaeker N, Naranjo C, Van Ranst M.
Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons.
J Clin Microbiol. 2007; 45(9):3022-30. |
|
|
| |
|
Van Bressem MF, Cassonnet P, Rector A, Desaintes C, Van Waerebeek K, Alfaro-Shigueto J, Van Ranst M, Orth G.
Genital warts in Burmeister's porpoises: characterization of Phocoena spinipinnis papillomavirus type 1 (PsPV-1) and evidence for a second, distantly related PsPV.
J Gen Virol. 2007; 88(Pt 7):1928-33. |
|
|
| |
|
Robaeys G, De Bie J, Van Ranst M, Buntinx F.
An extremely rare case of delusional parasitosis in a chronic hepatitis C patient during pegylated interferon alpha-2b and ribavirin treatment.
World J Gastroenterol. 2007; 13(16):2379-80. |
|
|
| |
|
Clement J, Neild GH, Maes P, Leirs H, Matthys P, Van Ranst M.
Symptomatic human hantavirus in the Americas.
Emerg Infect Dis. 2007 Feb;13(2):345-6. |
|
|
| |
|
Rector A, Lemey P, Tachezy R, Mostmans S, Ghim SJ, Van Doorslaer K, Roelke M, Bush M, Montali RJ, Joslin J, Burk RD, Jenson AB, Sundberg JP, Shapiro B, Van Ranst M.
Ancient papillomavirus-host co-speciation in Felidae.
Genome Biol. 2007; 8(4):R57. |
|
|
| |
|
Keyaerts E, Vijgen L, Pannecouque C, Van Damme E, Peumans W, Egberink H, Balzarini J, Van Ranst M.
Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle.
Antiviral Res. 2007; 75(3):179-87. |
|
|
| |
|
Van Doorslaer K, Rector A, Jenson AB, Sundberg JP, Van Ranst M, Ghim SJ.
Complete genomic characterization of a murine papillomavirus isolated from papillomatous lesions of a European harvest mouse (Micromys minutus).
J Gen Virol. 2007; 88(Pt 5):1484-8. |
|
|
| |
|
Rahman M, Sultana R, Ahmed G, Nahar S, Hassan ZM, Saiada F, Podder G, Faruque AS, Siddique AK, Sack DA, Matthijnssens J, Van Ranst M, Azim T.
Prevalence of G2P[4] and G12P[6] rotavirus, Bangladesh.
Emerg Infect Dis. 2007; 13(1):18-24. |
|
|
| |
|
Van Laethem K, De Munter P, Schrooten Y, Verbesselt R, Van Ranst M, Van Wijngaerden E, Vandamme AM.
No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs.
J Clin Virol. 2007; 39(1):43-7. |
|
|
| |
|
Rahman M, Hassan ZM, Zafrul H, Saiada F, Banik S, Faruque AS, Delbeke T, Matthijnssens J, Van Ranst M, Azim T.
Sequence analysis and evolution of group B rotaviruses.
Virus Res. 2007; 125(2):219-25. |
|
|
| |
|
Teughels W, Sliepen I, Quirynen M, Haake SK, Van Eldere J, Fives-Taylor P, Van Ranst M.
Human cytomegalovirus enhances A. actinomycetemcomitans adherence to cells.
J Dent Res. 2007; 86(2):175-80. |
|
|
| |
|
Maes P, Li S, Verbeeck J, Keyaerts E, Clement J, Van Ranst M.
Evaluation of the efficacy of disinfectants against Puumala hantavirus by real-time RT-PCR.
J Virol Methods. 2007; 141(1):111-5. |
|
|
| |
|
Rahman M, Matthijnssens J, Yang X, Delbeke T, Arijs I, Taniguchi K, Iturriza-Gómara M, Iftekharuddin N, Azim T, Van Ranst M.
Evolutionary history and global spread of the emerging g12 human rotaviruses.
J Virol. 2007; 81(5):2382-90. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Lin L, Verslype C, van Pelt JF, van Ranst M, Fevery J.
Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses.
Eur J Gastroenterol Hepatol. 2006; 18(12):1311-9. |
|
|
| |
|
McKnight CA, Wise AG, Maes RK, Howe C, Rector A, Van Ranst M, Kiupel M.
Papillomavirus-associated basosquamous carcinoma in an Egyptian fruit bat (Rousettus aegyptiacus).
J Zoo Wildl Med. 2006; 37(2):193-6. |
|
|
| |
|
Rehtanz M, Ghim SJ, Rector A, Van Ranst M, Fair PA, Bossart GD, Jenson AB.
Isolation and characterization of the first American bottlenose dolphin papillomavirus: Tursiops truncatus papillomavirus type 2.
J Gen Virol. 2006; 87(Pt 12):3559-65. |
|
|
| |
|
Maes P, Clement J, Groeneveld PH, Colson P, Huizinga TW, Van Ranst M.
Tumor necrosis factor-alpha genetic predisposing factors can influence clinical severity in nephropathia epidemica.
Viral Immunol. 2006; 19(3):558-64. |
|
|
| |
|
Rector A, Mostmans S, Van Doorslaer K, McKnight CA, Maes RK, Wise AG, Kiupel M, Van Ranst M.
Genetic characterization of the first chiropteran papillomavirus, isolated from a basosquamous carcinoma in an Egyptian fruit bat: the Rousettus aegyptiacus papillomavirus type 1.
Vet Microbiol. 2006; 117(2-4):267-75. |
|
|
| |
|
Vijgen L, Keyaerts E, Lemey P, Maes P, Van Reeth K, Nauwynck H, Pensaert M, Van Ranst M.
Evolutionary history of the closely related group 2 coronaviruses: porcine hemagglutinating encephalomyelitis virus, bovine coronavirus, and human coronavirus OC43.
J Virol. 2006; 80(14):7270-4. |
|
|
| |
|
Van Ranst M.
Influenza viruses in general, human strains, shift and drift, vaccination.
Verh K Acad Geneeskd Belg. 2006;68(2):77-80. |
|
|
| |
|
Maes P, Keyaerts E, Bonnet V, Clement J, Avsic-Zupanc T, Robert A, Van Ranst M.
Truncated recombinant Dobrava hantavirus nucleocapsid proteins induce strong, long-lasting immune responses in mice.
Intervirology. 2006; 49(5):253-60. |
|
|
| |
|
Balzarini J, Keyaerts E, Vijgen L, Egberink H, De Clercq E, Van Ranst M, Printsevskaya SS, Olsufyeva EN, Solovieva SE, Preobrazhenskaya MN.
Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.
Antiviral Res. 2006; 72(1):20-33. |
|
|
| |
|
Matthijnssens J, Rahman M, Yang X, Delbeke T, Arijs I, Kabue JP, Muyembe JJ, Van Ranst M.
G8 rotavirus strains isolated in the Democratic Republic of Congo belong to the DS-1-like genogroup.
J Clin Microbiol. 2006; 44(5):1801-9. |
|
|
| |
|
Verbeeck J, Maes P, Lemey P, Pybus OG, Wollants E, Song E, Nevens F, Fevery J, Delport W, Van der Merwe S, Van Ranst M.
Investigating the origin and spread of hepatitis C virus genotype 5a.
J Virol. 2006 May;80(9):4220-6. |
|
|
| |
|
Joossens S, Pierik M, Rector A, Vermeire S, Ranst MV, Rutgeerts P, Bossuyt X.
Mannan binding lectin (MBL) gene polymorphisms are not associated with anti-Saccharomyces cerevisiae (ASCA) in patients with Crohn's disease.
Gut. 2006 May;55(5):746. |
|
|
| |
|
Matthijnssens J, Rahman M, Martella V, Xuelei Y, De Vos S, De Leener K, Ciarlet M, Buonavoglia C, Van Ranst M.
Full genomic analysis of human rotavirus strain B4106 and lapine rotavirus strain 30/96 provides evidence for interspecies transmission.
J Virol. 2006; 80(8):3801-10. |
|
|
| |
|
Clement J, Maes P, Van Ranst M.
Which hantaviruses in India ?
Indian J Med Res. 2006 Jan;123(1):91-2. |
|
|
| |
|
Van Doorslaer K, Rector A, Vos P, Van Ranst M.
Genetic characterization of the Capra hircus papillomavirus: a novel close-to-root artiodactyl papillomavirus.
Virus Res. 2006; 118(1-2):164-9. |
|
|
| |
|
Kolacny D, Stalmans P, Wouters C, Van Ranst M, Casteels I.
Bilateral acute retinal necrosis in a 12-year-old girl.
J AAPOS. 2005; 9(6):599-601. |
|
|
| |
|
Robaeys G, Van Vlierberghe H, Matheï C, Van Ranst M, Bruckers L, Buntinx F; BASL Steering Committee; Benelux Study Group.
Similar compliance and effect of treatment in chronic hepatitis C resulting from intravenous drug use in comparison with other infection causes.
Eur J Gastroenterol Hepatol.2006; 18(2):159-66. |
|
|
| |
|
Balzarini J, Keyaerts E, Vijgen L, Vandermeer F, Stevens M, De Clercq E, Egberink H, Van Ranst M.
Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture.
J Antimicrob Chemother. 2006; 57(3):472-81. |
|
|
| |
|
Clement J, Maes P, Muthusethupathi M, Nainan G, van Ranst M.
First evidence of fatal hantavirus nephropathy in India, mimicking leptospirosis.
Nephrol Dial Transplant. 2006; 21(3):826-7. |
|
|
| |
|
Matthijnssens J, Rahman M, Van Ranst M.
Loop model: mechanism to explain partial gene duplications in segmented dsRNA viruses.
Biochem Biophys Res Commun. 2006; 340(1):140-4. |
|
|
| |
|
Van Laethem K, Schrooten Y, Dedecker S, Van Heeswijck L, Deforche K, Van Wijngaerden E, Van Ranst M, Vandamme AM.
A genotypic assay for the amplification and sequencing of gag and protease from diverse human immunodeficiency virus type 1 group M subtypes.
J Virol Methods. 2006; 132(1-2):181-6. |
|
|
| |
|
Keyaerts E, Vijgen L, Maes P, Duson G, Neyts J, Van Ranst M.
Viral load quantitation of SARS-coronavirus RNA using a one-step real-time RT-PCR.
Int J Infect Dis. 2006; 10(1):32-7. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Verbeeck J, Maes P, Wollants E, Van der Merwe S, Song E, Nevens F, Van Ranst M.
Use of a commercially available line probe assay for genotyping of hepatitis C virus 5a strains.
J Clin Microbiol. 2005; 43(12):6117-9. |
|
|
| |
|
Beuselinck K, van Ranst M, van Eldere J.
Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR.
J Clin Microbiol. 2005; 43(11):5541-6. |
|
|
| |
|
Vijgen L, Keyaerts E, Moës E, Maes P, Duson G, Van Ranst M.
Development of one-step, real-time, quantitative reverse transcriptase PCR assays for absolute quantitation of human coronaviruses OC43 and 229E.
J Clin Microbiol. 2005; 43(11):5452-6. |
|
|
| |
|
Dubois B, Lemmens R, Laffut W, Van Ranst M.
Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis.
Neurology. 2005; 65(7):1145-6. |
|
|
| |
|
Rahman M, Banik S, Faruque AS, Taniguchi K, Sack DA, Van Ranst M, Azim T.
Detection and characterization of human group C rotaviruses in Bangladesh.
J Clin Microbiol. 2005; 43(9):4460-5. |
|
|
| |
|
Meersseman W, Van Laethem K, Lagrou K, Wilms G, Sciot R, Van Ranst M, Vandamme A, Van Wijngaerden E.
Fatal brain necrosis in primary HIV infection.
Lancet. 2005; 366(9488):866. |
|
|
| |
|
Matheï C, Wollants E, Verbeeck J, Van Ranst M, Robaeys G, Van Damme P, Buntinx F.
Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium: association of genotype with clinical parameters and with sex- and drug-related risk behaviours.
Eur J Clin Microbiol Infect Dis. 2005; 24(8):514-22. |
|
|
| |
|
De Schrijver K, Maes I, Van Damme P, Tersago J, Moës E, Van Ranst M.
An outbreak of nosocomial hepatitis B virus infection in a nursing home for the elderly in Antwerp (Belgium).
Acta Clin Belg. 2005; 60(2):63-9. |
|
|
| |
|
Rahman M, Matthijnssens J, Nahar S, Podder G, Sack DA, Azim T, Van Ranst M.
Characterization of a novel P[25],G11 human group a rotavirus.
J Clin Microbiol. 2005; 43(7):3208-12. |
|
|
| |
|
Zlateva KT, Lemey P, Moës E, Vandamme AM, Van Ranst M.
Genetic variability and molecular evolution of the human respiratory syncytial virus subgroup B attachment G protein.
J Virol. 2005; 79(14):9157-67. |
|
|
| |
|
Rector A, Van Doorslaer K, Bertelsen M, Barker IK, Olberg RA, Lemey P, Sundberg JP, Van Ranst M.
Isolation and cloning of the raccoon (Procyon lotor) papillomavirus type 1 by using degenerate papillomavirus-specific primers.
J Gen Virol. 2005; 86(Pt 7):2029-33. |
|
|
| |
|
Van Assche G, Van Ranst M, Sciot R, Dubois B, Vermeire S, Noman M, Verbeeck J, Geboes K, Robberecht W, Rutgeerts P.
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.
N Engl J Med. 2005; 353(4):362-8. |
|
|
| |
|
Vijgen L, Keyaerts E, Lemey P, Moës E, Li S, Vandamme AM, Van Ranst M.
Circulation of genetically distinct contemporary human coronavirus OC43 strains.
Virology. 2005; 337(1):85-92. |
|
|
| |
|
Van Ranst M, Joossens M, Joossens S, Van Steen K, Pierik M, Vermeire S, Rutgeerts P.
Crohn's disease and month of birth.
Inflamm Bowel Dis. 2005; 11(6):597-9. |
|
|
| |
|
Matheï C, Robaeys G, Van Ranst M, Van Damme P, Buntinx F.
The epidemiology of hepatitis C among injecting drug users in Belgium.
Acta Gastroenterol Belg. 2005; 68(1):50-4. |
|
|
| |
|
Robaeys G, Matheï C, Van Ranst M, Buntinx F.
Substance use in Belgium : prevalence and management.
Acta Gastroenterol Belg. 2005 ; 68(1):46-9. |
|
|
| |
|
Robaeys G, Buntinx F, Bottieau E, Bourgeois S, Brenard R, Colle I, De Bie J, Matheï C, Mulkay JP, Van Damme P, Van Ranst M, Verrando R, Michielsen P, Bourgeois N, Brenard R, de Galocsy Ch, Delwaide J, Henrion J, Horsmans Y, Michielsen P, Reynaert H, Robaeys G, Sprengers D; Steering Committee of the Belgian Association for the Study of the Liver (BASL).
Guidelines for the management of chronic hepatitis C in patients infected after substance use.
Acta Gastroenterol Belg. 2005; 68(1):38-45. |
|
|
| |
|
Thoelen I, Verbeeck J, Wollants E, Maes P, Robaeys G, Matheï C, Buntinx F, Nevens F, Van Ranst M.
Frequency of the CCR5-Delta32 mutant allele is not increased in Belgian hepatitis C virus-infected patients.
Viral Immunol. 2005; 18(1):232-5. |
|
|
| |
|
Rahman M, Matthijnssens J, Goegebuer T, De Leener K, Vanderwegen L, van der Donck I, Van Hoovels L, De Vos S, Azim T, Van Ranst M.
Predominance of rotavirus G9 genotype in children hospitalized for rotavirus gastroenteritis in Belgium during 1999-2003.
J Clin Virol. 2005; 33(1):1-6. |
|
|
| |
|
Rahman M, Sultana R, Podder G, Faruque AS, Matthijnssens J, Zaman K, Breiman RF, Sack DA, Van Ranst M, Azim T.
Typing of human rotaviruses: nucleotide mismatches between the VP7 gene and primer are associated with genotyping failure.
Virol J. 2005; 2:24. |
|
|
| |
|
Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M.
Growth kinetics of SARS-coronavirus in Vero E6 cells.
Biochem Biophys Res Commun. 2005; 329(3):1147-51. |
|
|
| |
|
Vijgen L, Lemey P, Keyaerts E, Van Ranst M.
Genetic variability of human respiratory coronavirus OC43.
J Virol. 2005; 79(5):3223-4. |
|
|
| |
|
Zlateva KT, Maes P, Rahman M, Van Ranst M.
Chromatography paper strip sampling of enteric adenoviruses type 40 and 41 positive stool specimens.
Virol J. 2005; 10;2:6. |
|
|
| |
|
Moës E, Vijgen L, Keyaerts E, Zlateva K, Li S, Maes P, Pyrc K, Berkhout B, van der Hoek L, Van Ranst M.
A novel pancoronavirus RT-PCR assay: frequent detection of human coronavirus NL63 in children hospitalized with respiratory tract infections in Belgium.
BMC Infect Dis. 2005; 5(1):6. |
|
|
| |
|
Vijgen L, Keyaerts E, Moës E, Thoelen I, Wollants E, Lemey P, Vandamme AM, Van Ranst M.
Complete genomic sequence of human coronavirus OC43: molecular clock analysis suggests a relatively recent zoonotic coronavirus transmission event.
J Virol. 2005; 79(3):1595-604. |
|
|
| |
|
Rector A, Tachezy R, Van Doorslaer K, MacNamara T, Burk RD, Sundberg JP, Van Ranst M.
Isolation and cloning of a papillomavirus from a North American porcupine by using multiply primed rolling-circle amplification: the Erethizon dorsatum papillomavirus type 1.
Virology. 2005; 331(2):449-56. |
|
|
| |
|
Fanourgiakis P, Georgala A, Vekemans M, Triffet A, De Bruyn JM, Duchateau V, Martiat P, De Clercq E, Snoeck R, Wollants E, Rector A, Van Ranst M, Aoun M.
Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient.
Clin Infect Dis. 2005; 40(1):199-201. |
|
|
| |
|
Van Laethem K, Schrooten Y, Lemey P, Van Wijngaerden E, De Wit S, Van Ranst M, Vandamme AM.
A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene.
J Virol Methods. 2005; 123(1):25-34. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Maes P, Clement J, Gavrilovskaya I, Van Ranst M.
Hantaviruses: immunology, treatment, and prevention.
Viral Immunol. 2004; 17(4):481-97. |
|
|
| |
|
Derdelinckx I, Van Laethem K, Maes B, Schrooten Y, De Wit S, Florence E, Fransen K, Ribas SG, Marissens D, Moutschen M, Vaira D, Zissis G, Van Ranst M, Van Wijngaerden E, Vandamme AM.
Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.
J Acquir Immune Defic Syndr. 2004; 37(5):1664-6. |
|
|
| |
|
Zlateva KT, Van Ranst M.
Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia.
Pediatr Infect Dis J. 2004; 23(11):1065-6. |
|
|
| |
|
Maes P, Van Doren E, Denys B, Thoelen I, Rahman M, Vijgen L, Van Ranst M.
Poliovirus sampling by using sodium dodecyl sulfate/EDTA-pretreated chromatography paper strips.
Biochem Biophys Res Commun. 2004; 325(3):711-5. |
|
|
| |
|
Rector A, Bossart GD, Ghim SJ, Sundberg JP, Jenson AB, Van Ranst M.
Characterization of a novel close-to-root papillomavirus from a Florida manatee by using multiply primed rolling-circle amplification: Trichechus manatus latirostris papillomavirus type 1.
J Virol. 2004; 78(22):12698-702. |
|
|
| |
|
Wollants E, Maes P, Thoelen I, Vanneste F, Rahman M, Van Ranst M.
Evaluation of a norovirus sampling method using sodium dodecyl sulfate/EDTA-pretreated chromatography paper strips.
J Virol Methods. 2004; 122(1):45-8. |
|
|
| |
|
Ghim SJ, Rector A, Delius H, Sundberg JP, Jenson AB, Van Ranst M.
Equine papillomavirus type 1: complete nucleotide sequence and characterization of recombinant virus-like particles composed of the EcPV-1 L1 major capsid protein.
Biochem Biophys Res Commun. 2004; 324(3):1108-15. |
|
|
| |
|
Magiorkinis G, Magiorkinis E, Paraskevis D, Vandamme AM, Van Ranst M, Moulton V, Hatzakis A.
Phylogenetic analysis of the full-length SARS-CoV sequences: evidence for phylogenetic discordance in three genomic regions.
J Med Virol. 2004; 74(3):369-72. |
|
|
| |
|
Arbyn M, Dillner J, Van Ranst M, Buntinx F, Martin-Hirsch P, Paraskevaidis E.
Re: Have we resolved how to triage equivocal cervical cytology?
J Natl Cancer Inst. 2004; 96(18):1401-2. |
|
|
| |
|
Herman J, Van Ranst M, Snoeck R, Beuselinck K, Lerut E, Van Damme-Lombaerts R.
Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique.
Pediatr Transplant. 2004; 8(5):485-92. |
|
|
| |
|
Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M.
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.
Biochem Biophys Res Commun. 2004; 323(1):264-8. |
|
|
| |
|
Van Ranst M.
Chandipura virus: an emerging human pathogen?
Lancet. 2004 Sep 4-10;364(9437):821-2. |
|
|
| |
|
Maes P, Keyaerts E, Clement J, Bonnet V, Robert A, Van Ranst M.
Detection of Puumala hantavirus antibody with ELISA using a recombinant truncated nucleocapsid protein expressed in Escherichia coli.
Viral Immunol. 2004; 17(2):315-21. |
|
|
| |
|
Keyaerts E, Vijgen L, Chen L, Maes P, Hedenstierna G, Van Ranst M.
Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound.
Int J Infect Dis. 2004; 8(4):223-6. |
|
|
| |
|
Vijgen L, Keyaerts E, Zlateva K, Van Ranst M.
Identification of six new polymorphisms in the human coronavirus 229E receptor gene (aminopeptidase N/CD13).
Int J Infect Dis. 2004l; 8(4):217-22. |
|
|
| |
|
De Leener K, Rahman M, Matthijnssens J, Van Hoovels L, Goegebuer T, van der Donck I, Van Ranst M.
Human infection with a P[14], G3 lapine rotavirus.
Virology. 2004; 325(1):11-7. |
|
|
| |
|
Clement J, van der Groen G, Lameire N, Colson P, Van Ranst M.
Acute non-cardiogenic pulmonary edema in a 2003 French Puumala virus case: cautions and corrections.
Clin Nephrol. 2004; 61(5):364-5. |
|
|
| |
|
Keyaerts E, Ghijsels E, Lemey P, Maes P, Zachée P, Daelemans R, Vervoort T, Mertens G, Van Ranst M, Clement J.
Plasma exchange-associated immunoglobulin m-negative hantavirus disease after a camping holiday in southern france.
Clin Infect Dis. 2004; 38(10):1350-6. |
|
|
| |
|
Rector A, Tachezy R, Van Ranst M.
A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification.
J Virol. 2004; 78(10):4993-8. |
|
|
| |
|
Maes B, Schrooten Y, Snoeck J, Derdelinckx I, Van Ranst M, Vandamme AM, Van Laethem K.
Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory.
J Virol Methods. 2004; 119(1):45-9. |
|
|
| |
|
Van Hoeyveld E, Houtmeyers F, Massonet C, Moens L, Van Ranst M, Blanckaert N, Bossuyt X.
Detection of single nucleotide polymorphisms in the mannose-binding lectin gene using minor groove binder-DNA probes.
J Immunol Methods. 2004; 287(1-2):227-30. |
|
|
| |
|
Zlateva KT, Lemey P, Vandamme AM, Van Ranst M.
Molecular evolution and circulation patterns of human respiratory syncytial virus subgroup a: positively selected sites in the attachment g glycoprotein.
J Virol. 2004; 78(9):4675-83. |
|
|
| |
|
Rahman M, Goegebuer T, De Leener K, Maes P, Matthijnssens J, Podder G, Azim T, Van Ranst M.
Chromatography paper strip method for collection, transportation, and storage of rotavirus RNA in stool samples.
J Clin Microbiol. 2004; 42(4):1605-8. |
|
|
| |
|
Lewi L, Van Schoubroeck D, Van Ranst M, Bries G, Emonds MP, Arabin B, Welch R, Deprest J.
Successful patching of iatrogenic rupture of the fetal membranes.
Placenta. 2004; 25(4):352-6. |
|
|
| |
|
Thoelen I, Moës E, Lemey P, Mostmans S, Wollants E, Lindberg AM, Vandamme AM, Van Ranst M.
Analysis of the serotype and genotype correlation of VP1 and the 5' noncoding region in an epidemiological survey of the human enterovirus B species.
J Clin Microbiol. 2004; 42(3):963-71. |
|
|
| |
|
Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J.
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
J Natl Cancer Inst. 2004; 96(4):280-93. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Clement J, Lameire N, Keyaerts E, Maes P, Van Ranst M.
Hantavirus infections in Europe.
Lancet Infect Dis. 2003 Dec;3(12):752-3. |
|
|
| |
|
Derdelinckx I, Van Laethem K, Maes B, Schrooten Y, De Schouwer K, De Wit S, Fransen K, García Ribas S, Moutschen M, Vaira D, Zissis G, Van Ranst M, Van Wijngaerden E, Vandamme AM.
Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes.
FEMS Immunol Med Microbiol. 2003; 39(2):119-24. |
|
|
| |
|
Flamaing J, Engelmann I, Joosten E, Van Ranst M, Verhaegen J, Peetermans WE.
Viral lower respiratory tract infection in the elderly: a prospective in-hospital study.
Eur J Clin Microbiol Infect Dis. 2003; 22(12):720-5. |
|
|
| |
|
Vijgen L, Van Essche M, Van Ranst M.
Absence of the Kilifi mutation in the rhinovirus-binding domain of ICAM-1 in a Caucasian population.
Genet Test. 2003; 7(2):159-61. |
|
|
| |
|
Thoelen I, Lemey P, Van Der Donck I, Beuselinck K, Lindberg AM, Van Ranst M.
Molecular typing and epidemiology of enteroviruses identified from an outbreak of aseptic meningitis in Belgium during the summer of 2000.
J Med Virol. 2003; 70(3):420-9. |
|
|
| |
|
Clement J, Frans J, Van Ranst M.
Human Tula virus infection or rat-bite fever?
Eur J Clin Microbiol Infect Dis. 2003; 22(5):332-3. |
|
|
| |
|
Rahman M, De Leener K, Goegebuer T, Wollants E, Van der Donck I, Van Hoovels L, Van Ranst M.
Genetic characterization of a novel, naturally occurring recombinant human G6P[6] rotavirus.
J Clin Microbiol. 2003; 41(5):2088-95. |
|
|
| |
|
Van der Donck I, Van Hoovels L, De Leener K, Goegebuer T, Vanderwegen L, Frans J, Rahman M, Van Ranst M.
Severe diarrhea due to rotavirus infection in a Belgian hospital 1981-2002.
Acta Clin Belg. 2003; 58(1):12-8. |
|
|
| |
|
Pislaru SV, Van Ranst M, Pislaru C, Szelid Z, Theilmeier G, Ossewaarde JM, Holvoet P, Janssens S, Verbeken E, Van de Werf FJ.
Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs.
Cardiovasc Res. 2003; 57(3):834-42. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Rector A, Azzi N, Liesnard C, Zlateva K, Van Beers D, Snoeck R, Van Ranst M.
Use of polymerase chain reaction for diagnosis of disseminated adenovirus infection.
Pediatr Infect Dis J. 2002; 21(12):1176-8. |
|
|
| |
|
Van Vaerenbergh K, De Geest S, Derdelinckx I, Bobbaers H, Carbonez A, Deschamps A, De Graeve V, De Saar V, Ceunen H, De Smet K, Maes B, Peetermans W, Schrooten Y, Desmyter J, De Clercq E, Van Ranst M, Van Wijngaerden E, Vandamme AM.
A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure.
Antivir Chem Chemother. 2002; 13(4):231-40. |
|
|
| |
|
Ying C, Van Pelt JF, Van Lommel A, Van Ranst M, Leyssen P, De Clercq E, Neyts J.
Sulphated and sulphonated polymers inhibit the initial interaction of hepatitis B virus with hepatocytes.
Antivir Chem Chemother. 2002; 13(3):157-64. |
|
|
| |
|
Bodéus M, Van Ranst M, Bernard P, Hubinont C, Goubau P.
Anticytomegalovirus IgG avidity in pregnancy: a 2-year prospective study.
Fetal Diagn Ther. 2002; 17(6):362-6. |
|
|
| |
|
Vijgen L, Van Gysel M, Rector A, Thoelen I, Esters N, Ceelen T, Vangoidsenhoven E, Vermeire S, Rutgeerts P, Van Ranst M.
Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
Genes Immun. 2002; 3(7):400-6. |
|
|
| |
|
Tachezy R, Duson G, Rector A, Jenson AB, Sundberg JP, Van Ranst M.
Cloning and genomic characterization of Felis domesticus papillomavirus type 1.
Virology. 2002; 301(2):313-21. |
|
|
| |
|
Vandecasteele SJ, Frans J, Van Ranst M.
Contamination management of broad-range ribosomal DNA PCR: where is the evidence?
J Clin Microbiol. 2002; 40(10):3885. |
|
|
| |
|
Robaeys G, Matheï C, Buntinx F, Van Ranst M.
Management of hepatitis C virus infections in intravenous drug users.
Acta Gastroenterol Belg. 2002; 65(2):99-100. |
|
|
| |
|
Tachezy R, Rector A, Havelkova M, Wollants E, Fiten P, Opdenakker G, Jenson B, Sundberg J, Van Ranst M.
Avian papillomaviruses: the parrot Psittacus erithacus papillomavirus (PePV) genome has a unique organization of the early protein region and is phylogenetically related to the chaffinch papillomavirus.
BMC Microbiol. 2002; 2:19. |
|
|
| |
|
Tachezy J, Tachezy R, Hampl V, Sedinová M, Vanacová S, Vrlík M, Van Ranst M, Flegr J, Kuldaa J.
Cattle pathogen tritrichomonas foetus (Riedmüller, 1928) and pig commensal Tritrichomonas suis (Gruby & Delafond, 1843) belong to the same species.
J Eukaryot Microbiol. 2002; 49(2):154-63. |
|
|
| |
|
Stragier I, Snoeck R, De Clercq E, Van Den Oord JJ, Van Ranst M, De Greef H.
Local treatment of HPV-induced skin lesions by Cidofovir.
J Med Virol. 2002; 67(2):241-5. |
|
|
| |
|
Van Vaerenbergh K, Harrer T, Schmit JC, Carbonez A, Fontaine E, Kurowski M, Grünke M, Löw P, Rascu A, Schmidt B, Schmitt M, Thoelen I, Walter H, Van Laethem K, Van Ranst M, Desmyter J, De Clercq E, Vandamme AM.
Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients.
AIDS Res Hum Retroviruses. 2002; 18(6):419-26. |
|
|
| |
|
Vandecasteele SJ, Peetermans WE, Merckx R, Van Ranst M, Van Eldere J.
Use of gDNA as internal standard for gene expression in staphylococci in vitro and in vivo.
Biochem Biophys Res Commun. 2002; 291(3):528-34. |
|
|
| |
|
Einstein MH, Cruz Y, El-Awady MK, Popescu NC, DiPaolo JA, van Ranst M, Kadish AS, Romney S, Runowicz CD, Burk RD.
Utilization of the human genome sequence localizes human papillomavirus type 16 DNA integrated into the TNFAIP2 gene in a fatal cervical cancer from a 39-year-old woman.
Clin Cancer Res. 2002; 8(2):549-54. |
|
|
| |
|
Van Dooren S, Switzer WM, Heneine W, Goubau P, Verschoor E, Parekh B, De Meurichy W, Furley C, Van Ranst M, Vandamme AM.
Lack of evidence for infection with simian immunodeficiency virus in bonobos.
AIDS Res Hum Retroviruses. 2002; 18(3):213-6. |
|
|
| |
|
Thoelen I, Duson G, Wollants E, Van Ranst M.
Analysis of genetic heterogeneity in the HCAR adenovirus-binding Ig1 domain in a Caucasian Flemish population.
BMC Genet. 2002; 3:1. |
|
|
| |
|
Struyf F, Posavad CM, Keyaerts E, Van Ranst M, Corey L, Spear PG.
Search for polymorphisms in the genes for herpesvirus entry mediator, nectin-1, and nectin-2 in immune seronegative individuals.
J Infect Dis. 2002 ;185(1):36-44. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Van Dooren S, Salemi M, Pourrut X, Peeters M, Delaporte E, Van Ranst M, Vandamme AM.
Evidence for a second simian T-cell lymphotropic virus type 3 in Cercopithecus nictitans from Cameroon.
J Virol. 2001 Dec;75(23):11939-41. |
|
|
| |
|
Thoelen I, Keyaerts E, Lindberg M, Van Ranst M.
Characterization of a cDNA encoding the bovine coxsackie and adenovirus receptor.
Biochem Biophys Res Commun. 2001; 288(4):805-8. |
|
|
| |
|
Rector A, Lemey P, Laffut W, Keyaerts E, Struyf F, Wollants E, Vermeire S, Rutgeerts P, Van Ranst M.
Mannan-binding lectin (MBL) gene polymorphisms in ulcerative colitis and Crohn's disease.
Genes Immun. 2001; 2(6):323-8. |
|
|
| |
|
Clement J, van Ranst M, Lamiere N.
Hantavirus infection complicated with ARF and spontaneous perinephric haemorrhage.
Nephron. 2001; 89(2):241-2. |
|
|
| |
|
Thoelen I, Magnusson C, Tågerud S, Polacek C, Lindberg M, Van Ranst M.
Identification of alternative splice products encoded by the human coxsackie-adenovirus receptor gene.
Biochem Biophys Res Commun. 2001; 287(1):216-22. |
|
|
| |
|
Snoeck R, Bossens M, Parent D, Delaere B, Degreef H, Van Ranst M, Noël JC, Wulfsohn MS, Rooney JF, Jaffe HS, De Clercq E.
Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection.
Clin Infect Dis. 2001; 33(5):597-602. |
|
|
| |
|
Van Vaerenbergh K, Debaisieux L, De Cabooter N, Declercq C, Desmet K, Fransen K, Maes B, Marissens D, Miller K, Muyldermans G, Sprecher S, Stuyver L, Vaira D, Verhofstede C, Zissis G, Van Ranst M, De Clercq E, Desmyter J, Vandamme AM.
Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium.
Antivir Ther. 2001; 6(1):63-70. |
|
|
| |
|
Rector A, Vermeire S, Thoelen I, Keyaerts E, Struyf F, Vlietinck R, Rutgeerts P, Van Ranst M.
Analysis of the CC chemokine receptor 5 (CCR5) delta-32 polymorphism in inflammatory bowel disease.
Hum Genet. 2001; 108(3):190-3. |
|
|
| |
|
Bogaerts J, Ahmed J, Akhter N, Begum N, Rahman M, Nahar S, Van Ranst M, Verhaegen J.
Sexually transmitted infections among married women in Dhaka, Bangladesh: unexpected high prevalence of herpes simplex type 2 infection.
Sex Transm Infect. 2001;77(2):114-9. |
|
|
| |
|
Lazzarotto T, Galli C, Pulvirenti R, Rescaldani R, Vezzo R, La Gioia A, Martinelli C, La Rocca S, Agresti G, Grillner L, Nordin M, van Ranst M, Combs B, Maine GT, Landini MP.
Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay.
Clin Diagn Lab Immunol. 2001; 8(1):196-8. |
|
|
| |
|
Fontaine E, Riva C, Peeters M, Schmit JC, Delaporte E, Van Laethem K, Van Vaerenbergh K, Snoeck J, Van Wijngaerden E, De Clercq E, Van Ranst M, Vandamme AM.
Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 sybtypes A through J.
J Acquir Immune Defic Syndr. 2001 Nov; 28(3):254-8 |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Witters I, Van Ranst M, Fryns JP.
Cytomegalovirus reactivation in pregnancy and subsequent isolated bilateral hearing loss in the infant.
Genet Couns. 2000; 11(4):375-8. |
|
|
| |
|
Sasse A, Liesnard C, van der Groen G, Burtonboy G, Plum J, Sondag-Thull D, Sprecher S, Van Ranst M, Zissis G, Desmyter J.
Recent increase in diagnoses of HIV infections based on surveillance system data in Belgium.
AIDS. 2000; 14(17):2798-800. |
|
|
| |
|
Clement J, Van Ranst M, Leirs H.
The results of tick-bone encephalitis (TBE)-vaccination.
Am J Trop Med Hyg. 2000; 62(3):325-6. |
|
|
| |
|
Clement J, Colson P, Van Ranst M.
Dengue versus hantavirus in CNS infections.
Lancet. 2000; 355(9221):2163-4. |
|
|
| |
|
Struyf F, Thoelen I, Charlier N, Keyaerts E, Van der Donck I, Wuu J, Van Ranst M.
Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium.
Hum Hered. 2000; 50(5):304-7. |
|
|
| |
|
Van Laethem K, Schmit JC, Pelemans H, Balzarini J, Witvrouw M, Pérez-Pérez MJ, Camarasa MJ, Esnouf RM, Aquaro S, Cenci A, Perno CF, Hermans P, Sprecher S, Ruiz L, Clotet B, Van Wijngaerden E, Van Ranst M, Desmyter J, De Clercq E, Vandamme AM.
Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients.
AIDS Res Hum Retroviruses. 2000; 16(9):825-33. |
|
|
| |
|
Yersin C, Bovet P, Mérien F, Clement J, Laille M, Van Ranst M, Perolat P.
Pulmonary haemorrhage as a predominant cause of death in leptospirosis in Seychelles.
Trans R Soc Trop Med Hyg. 2000 Jan-Feb;94(1):71-6. |
|
|
| |
|
Van Laethem K, Witvrouw M, Balzarini J, Schmit JC, Sprecher S, Hermans P, Leal M, Harrer T, Ruiz L, Clotet B, Van Ranst M, Desmyter J, De Clercq E, Vandamme AM.
Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir.
AIDS. 2000; 14(4):469-71. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Van Laethem K, Van Vaerenbergh K, Schmit JC, Sprecher S, Hermans P, De Vroey V, Schuurman R, Harrer T, Witvrouw M, Van Wijngaerden E, Stuyver L, Van Ranst M, Desmyter J, De Clercq E, Vandamme AM.
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations.
J Acquir Immune Defic Syndr. 1999; 22(2):107-18. |
|
|
| |
|
Bogaerts J, Ahmed J, Akhter N, Begum N, Van Ranst M, Verhaegen J.
Sexually transmitted infections in a basic healthcare clinic in Dhaka, Bangladesh: syndromic management for cervicitis is not justified.
Sex Transm Infect. 1999; 75(6):437-8. |
|
|
| |
|
Clement J, van Ranst M.
Hantavirus infections in Belgium
Verh K Acad Geneeskd Belg. 1999;61(6):701-17; discussion 718-9. |
|
|
| |
|
Tachezy R, Mikysková I, Saláková M, Van Ranst M.
Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism.
Hum Genet. 1999; 105(6):564-6. |
|
|
| |
|
Sundberg JP, Van Ranst M, Montali R, Homer BL, Miller WH, Rowland PH, Scott DW, England JJ, Dunstan RW, Mikaelian I, Jenson AB.
Feline papillomas and papillomaviruses.
Vet Pathol. 2000; 37(1):1-10. |
|
|
| |
|
Clement J, Neild G, Hinrichsen SL, Crescente JA, Van Ranst M.
Urban leptospirosis versus urban hantavirus infection in Brazil.
Lancet. 1999; 354(9194):2003-4. |
|
|
| |
|
Struyf F, Lemmens A, Valadas E, Verhaegen J, Van Ranst M.
Usefulness of immunochromatographic detection of antibodies to Mycobacterium tuberculosis as an adjunct to auramine staining for rapid diagnosis of tuberculosis in a low-prevalence setting.
Eur J Clin Microbiol Infect Dis. 1999; 18(10):740-2. |
|
|
| |
|
Tachezy R, Hamsíková E, Hájek T, Mikysková I, Smahel M, Van Ranst M, Kanka J, Havránková A, Rob L, Guttner V, Slavík V, Anton M, Kratochvíl B, Kotrsová L, Vonka V.
Human papillomavirus genotype spectrum in Czech women: correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles.
J Med Virol. 1999; 58(4):378-86. |
|
|
| |
|
Vandamme AM, Van Laethem K, Schmit JC, Van Wijngaerden E, Reynders M, Debyser Z, Witvrouw M, Van Ranst M, De Clercq E, Desmyter J.
Long-term stability of human immunodeficiency virus viral load and infectivity in whole blood.
Eur J Clin Invest. 1999; 29(5):445-52 |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Dits H, Frans E, Wilmer A, Van Ranst M, Fevery J, Bobbaers H.
Varicella-zoster virus infection associated with acute liver failure.
Clin Infect Dis. 1998; 27(1):209-10. |
|
|
| |
|
Vandamme AM, Salemi M, Van Brussel M, Liu HF, Van Laethem K, Van Ranst M, Michels L, Desmyter J, Goubau P.
African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.
J Virol. 1998; 72(5):4327-40. |
|
|
| |
|
Snoeck R, Wellens W, Desloovere C, Van Ranst M, Naesens L, De Clercq E, Feenstra L.
Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine].
J Med Virol. 1998; 54(3):219-25. |
|
|
| |
|
Van Ranst M, Desmyter J.
Post-exposure prophylaxis after accidental prion inoculation.
Lancet. 1998; 351(9102):600. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Král'ová I, Van de Peer Y, Jirku M, Van Ranst M, Scholz T, Lukes J.
Phylogenetic analysis of a fish tapeworm, Proteocephalus exiguus, based on the small subunit rRNA gene.
Mol Biochem Parasitol. 1997; 84(2):263-6. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Drmota T, Proost P, Van Ranst M, Weyda F, Kulda J, Tachezy J.
Iron-ascorbate cleavable malic enzyme from hydrogenosomes of Trichomonas vaginalis: purification and characterization
Mol Biochem Parasitol. 1996; 83(2):221-34. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Snoeck R, Van Ranst M, Andrei G, De Clercq E, De Wit S, Poncin M, Clumeck N.
Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue.
N Engl J Med. 1995; 333(14):943-4. |
|
|
| |
|
Sova P, van Ranst M, Gupta P, Balachandran R, Chao W, Itescu S, McKinley G, Volsky DJ.
Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo.
J Virol. 1995; 69(4):2557-64. |
|
|
| |
|
Van Cutsem E, Snoeck R, Van Ranst M, Fiten P, Opdenakker G, Geboes K, Janssens J, Rutgeerts P, Vantrappen G, de Clercq E, et al.
Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
J Med Virol. 1995; 45(2):230-5. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Tachezy R, Van Ranst MA, Cruz Y, Burk RD.
Analysis of short novel human papillomavirus sequences.
Biochem Biophys Res Commun. 1994; 204(2):820-7. |
|
|
| |
|
Delius H, Van Ranst MA, Jenson AB, zur Hausen H, Sundberg JP.
Canine oral papillomavirus genomic sequence: a unique 1.5-kb intervening sequence between the E2 and L2 open reading frames.
Virology. 1994; 204(1):447-52. |
|
|
| |
|
Kadish AS, Romney SL, Ledwidge R, Tindle R, Fernando GJ, Zee SY, Van Ranst MA, Burk RD.
Cell-mediated immune responses to E7 peptides of human papillomavirus (HPV) type 16 are dependent on the HPV type infecting the cervix whereas serological reactivity is not type-specific.
J Gen Virol. 1994; 75(Pt 9):2277-84. |
|
|
| |
|
Sundberg JP, Smith EK, Herron AJ, Jenson AB, Burk RD, Van Ranst M.
Involvement of canine oral papillomavirus in generalized oral and cutaneous verrucosis in a Chinese Shar Pei dog.
Vet Pathol. 1994; 31(2):183-7. |
|
|
| |
|
Tan CH, Tachezy R, Van Ranst M, Chan SY, Bernard HU, Burk RD.
The Mastomys natalensis papillomavirus: nucleotide sequence, genome organization, and phylogenetic relationship of a rodent papillomavirus involved in tumorigenesis of cutaneous epithelia.
Virology. 1994; 198(2):534-41. |
|
|
| |
|
Tachezy R, Hamsikova E, Valvoda J, Van Ranst M, Betka J, Burk RD, Vonka V.
Antibody response to a synthetic peptide derived from the human papillomavirus type 6/11 L2 protein in recurrent respiratory papillomatosis: correlation between Southern blot hybridization, polymerase chain reaction, and serology.
J Med Virol. 1994; 42(1):52-9. |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Van Ranst M, Kaplan JB, Burk RD.
Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations.
J Gen Virol. 1992; 73(Pt 10):2653-60. |
|
|
| |
|
Van Ranst M, Fuse A, Fiten P, Beuken E, Pfister H, Burk RD, Opdenakker G.
Human papillomavirus type 13 and pygmy chimpanzee papillomavirus type 1: comparison of the genome organizations.
Virology. 1992; 190(2):587-96. |
|
|
| |
|
Fuse A, Simizu B, Van Ranst M, Opdenakker G, Van Damme J.
The induction of IL-6 and gelatinase B by IL-1 in mouse cell lines transformed with bovine papillomavirus: decreased production in tumorigenic cells. Lymphokine Cytokine Res.
1992; 11(4):215-20. |
|
|
| |
|
Van Ranst M, Tachezy R, Pruss J, and Burk RD
Primary structure of the E6 protein of Micromys minutus papillomavirus and Mastomys natalensis papillomavirus.
Nucleic Acids Res. 1992; 20(11):2889. |
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Vandekerckhove F, Opdenakker G, Van Ranst M, Lenaerts JP, Put W, Billiau A, Van Damme J.
Bradykinin induces interleukin-6 and synergizes with interleukin-1.
Lymphokine Cytokine Res. 1991;10(4):285-9. |
|
|
| |
|
Van Ranst M, Fuse A, Sobis H, De Meurichy W, Syrjänen SM, Billiau A, Opdenakker G.
A papillomavirus related to HPV type 13 in oral focal epithelial hyperplasia in the pygmy chimpanzee.
J Oral Pathol Med. 1991;20(7):325-31. |
|
|
| |
|
Van Ranst M, Norga K, Masure S, Proost P, Vandekerckhove F, Auwerx J, Van Damme J, Opdenakker G
The cytokine-protease connection: identification of a 96-kD THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers.
Cytokine. 1991;3(3):231-9. |
|
|
| |
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
Inge Thoelen |
Genetic Analysis of the Human Cellular Receptor for Coxsackie B Viruses and Adenoviruses and Molecular Epidemiology of Group B Enteroviruses
Defended 22 December 2004
|
|
|
| |
|
Frank Struyf |
Genetic susceptibility to herpesviral infections
Defended 6 June 2004
|
|
|
| |
|
Annabel Rector |
Strategies for Detection of Novel Genetically Divergent Papillomaviruses and Study of the Genetic Diversity and Molecular Evolution of the Papillomaviridae
Defended 30 May 2005
|
|
|
| |
|
Leen Vijgen |
Molecular evolution of group 2 coronaviruses
Defended 7 December 2005
|
|
|
| |
|
Els Keyaerts |
Evaluation of antiviral strategies against the severe acute respiratory syndrome coronavirus
Defended 31 May 2006
|
|
|
| |
|
Kalina Zlateva |
Molecular epidemiology and evolution of subgroup A and B human respiratory syncytial viruses
Defended 7 December 2006
|
|
|
| |
|
Piet Maes |
Hantaviruses: Classification, Diagnosis and Prevention
Defended 21 December 2007
|
|
|
| |
|
Mustafizur Rahman |
Molecular Epidemiology of Human Group A Rotaviruses
Defended in April 2008
|
|
|
| |
|
Jelle Matthijnssens |
Genetic Diversity and Classification of Human and Animal Rotaviruses
Defended 22 December 2008
|
|
|
| |
|
|
|
|
| |
|
|
|
|
